Search clinical trials for: Narcotic Withdrawal

Total 15033 results

Joshua A. Lile, Ph.D.

Not yet recruiting

Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice (BED(In)(44))

Opioid Use Disorder
Takeda

Recruiting

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Plaque Psoriasis

United States, Canada
USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA)

Recruiting

Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids

Opioid Withdrawal (Disorder)

United States
BioXcel Therapeutics Inc
Lotus Clinical Research, LLC

Recruiting

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder | Schizo Affective Disorder | Agitation,Psychomotor | Schizophreniform Disorders

United States
University of Pennsylvania

Recruiting

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal (UH3)

Opioid Use | Opiate Withdrawal Syndrome

United States
HELP for NOWS Consortium
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach (OPTimize NOW)

Neonatal Opiate Withdrawal Syndrome

United States
Salem Anaesthesia Pain Clinic

Recruiting

Kratom Use Disorder Management Using Clonidine and/or Buprenorphine

Withdrawal Syndrome

Canada
Emory University
National Institute on Drug Abuse (NIDA)

Recruiting

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 (VNS in OUD UH3)

Opioid Use Disorder | Opioid Use | Withdrawal Symptoms

United States
Washington University School of Medicine

Recruiting

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE) (Patch BRIDGE)

Pregnancy Complications | Pregnancy Related | Pregnancy, High Risk | Opioid Use Disorder | Buprenorphine Withdrawal

United States
Addinex Technologies, Inc.
Centers for Disease Control and Prevention

Recruiting

Suboxone Dispenser for OUD

Opioid Use Disorder | Opioid Withdrawal

United States
Massachusetts General Hospital

Recruiting

Night Respite for Postpartum Mothers With SUD

Sleep Disorder | Opioid Use Disorder | Neonatal Opioid Withdrawal | Maternal Drugs Affecting Fetus | Postpartum Mood Disturbance

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Yale University; Clinilabs, Inc.; BioXcel...

Recruiting

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal

United States
Johns Hopkins University

Recruiting

Evaluating Buspirone to Treat Opioid Withdrawal

Anxiety | Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
King Abdullah International Medical Research Center

Recruiting

Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs. (PROMISE)

Dexmedetomidine | Withdrawal Symptoms | Midazolam | Failure of Extubation

Saudi Arabia
United Health Services Hospitals, Inc.
Binghamton University

Recruiting

Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing

Opioid Use Disorder | Opioid Withdrawal

United States
Spark Biomedical, Inc.
Hazelden Betty Ford Foundation; Gaudenzia, Inc.

Recruiting

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE)

Opioid-use Disorder | Opioid Withdrawal

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Recruiting

Assessing a Clinically-meaningful Opioid Withdrawal Phenotype

Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
Chengdu University of Traditional Chinese Medicine

Recruiting

EA for Protracted Withdrawal of OUD

Opioid-Related Disorders

China
Peking University

Recruiting

Sedation Compaired With Anesthesia With THRIVE in Endotracheal Intubation With Difficult Airways

Airway Control | Sedative, Hypnotic, or Anxiolytic Withdrawal

China
Evon Medics LLC
National Institute on Drug Abuse (NIDA); Howard University; Family and Medical... and other collaborators

Recruiting

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder (CBOT-OUD)

Withdrawal Symptoms | Craving | Opioid Use Disorder, Moderate | Opioid Use Disorder, Severe | Negative Affectivity

United States
Massachusetts General Hospital

Recruiting

Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD

Sleep Disorder | Restless Legs Syndrome | Opioid-use Disorder | Opioid Withdrawal

United States
University of Erlangen-Nürnberg Medical School

Recruiting

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Psoriatic Arthritis | Withdrawal | Reduction

Germany
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Recruiting

An Innovative Intervention for OUD Treatment (Bridge)

Opioid-Related Disorders | Opioid Dependence | Opioid Withdrawal | Opioid Addiction

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

Opioid-Use Disorder

United States
University of British Columbia
Vancouver Coastal Health

Recruiting

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Opioid Use Disorder

Canada
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study (MOMs-INO)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome | Drug Abuse in Pregnancy

United States
Aphios

Not yet recruiting

Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction

Addiction | Opioid Dependence | Opioid Withdrawal
Yonsei University

Not yet recruiting

Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease

Healthy Participants With Moderate and High Cardiovascular Risk

Korea, Republic of
National University Hospital, Singapore

Recruiting

Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair

Inguinal Hernia

Singapore
Meir Medical Center

Completed

Methadone vs. Transdermal Fentanyl for Opioid Withdrawal Syndrome

Delirium in the Intensive Care Unit

Israel
Advancing Clinical Trials in Neonatal Opioid Withdrawal...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Neonatal Opioid Withdrawal Syndrome

United States
University of Vermont
National Institute on Drug Abuse (NIDA); Johns Hopkins University; University... and other collaborators

Completed

Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions (MOTHER DYAD)

Opioid-use Disorder | Neonatal Abstinence Syndrome | Opioid Withdrawal | Neonatal Opioid Withdrawal Syndrome

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study (MOMs-CMA)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal (RELEASE)

Opioid Withdrawal

United States
Dhaka Medical College

Enrolling by invitation

The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy

Focal Epilepsy

Bangladesh
PhotoPharmics, Inc.
National Institute on Drug Abuse (NIDA); Brigham Young University

Completed

Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety

Opioid-use Disorder

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT)

Opioid-use Disorder

United States
Emory University
National Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNY

Completed

Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders (nVNS in OUDs)

Substance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance Withdrawal

United States
Daniel Benjamin
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (PTN_POPS)

Heart Failure | Epilepsy | Pain | Pneumonia | Sepsis | Inflammation | Hypertension | Chronic Kidney Diseases | Hemophilia | Schizophrenia | Central Nervous System Infections | Nosocomial Pneumonia | Insomnia | Anxiety | Bipolar Disorder | Neutropenia | Staphylococcal Infections | Bradycardia | Seizures | Urinary Tract Infections | Pulmonary... and other conditions

United States, Canada, United Kingdom, Israel, Singapore
Johns Hopkins University
Dalio Foundation

Completed

Oral Cannabidiol for Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
New York State Psychiatric Institute

Suspended

A Study of SPG Block for Opioid Withdrawal

Opioid Use Disorder

United States
University of Vermont
National Institute on Drug Abuse (NIDA); Johns Hopkins University; Food and Drug...

Active, not recruiting

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder

Tobacco Use Disorder

United States
New York State Psychiatric Institute

Suspended

Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal

Opioid Overdose

United States
Chiesi Farmaceutici S.p.A.

Terminated

CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome (NOWSHINE)

Neonatal Opioid Withdrawal Syndrome

United States
Masimo Corporation

Enrolling by invitation

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Opioid Use Disorder

United States
Women and Infants Hospital of Rhode Island
National Institute of General Medical Sciences (NIGMS)

Withdrawn

Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)

Neonatal Opioid Withdrawal Syndrome

United States
Chinese University of Hong Kong
Queen Elizabeth Hospital, Hong Kong; Alice Ho Miu Ling Nethersole Hospital; Tseung...

Completed

Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis

Colitis, Ulcerative | Aminosalicylic Acid

Hong Kong
Wilkes University

Completed

Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19

COVID-19 | Iatrogenic Disease | ARDS | Withdrawal Syndrome

United States
University of Pennsylvania

Completed

Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal (PGB-LOF)

Opioid Withdrawal

United States

Search clinical trials for: Narcotic Withdrawal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations